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Background: Totally implantable access port (TIAP) provides reliable, long term vascular access with minimal risk of infection and al-
lows patients normal physical activity. With wide use of ports, new complications have been encountered. We analyzed TIAP related 
complications and evaluated the outcomes of two different percutaneous routes of access to superior vena cava. 
Methods: All 172 patients who underwent port insertion with internal jugular approach (Group 1, n = 92) and subclavian approach 
(Group 2, n = 79) between August 2011 and May 2013 in a single center were analyzed, retrospectively. Medical records were analyzed 
to compare the outcomes and the occurrence of port related complications between two different percutaneous routes of access to 
superior vena cava. 
Results: Median follow-up for TIAP was 278 days (range, 1-1868). Twenty four complications were occurred (14.0%), including pneu-
mothorax (n = 1, 0.6%), migration/malposition (n = 4, 2.3%), pinch-off syndrome (n = 4, 2.3%), malfunction (n = 2, 1.1%), infection (n = 8, 
4.7%), and venous thrombosis (n = 5, 2.9%). The overall incidence was 8.7% and 20.3% in each group (p = 0.030). Mechanical compli-
cations except infectious and thrombotic complications were more often occurred in group 2 (p = 0.033). The mechanical complica-
tion free probability is significantly higher in group 1 (p = 0.040). 
Conclusions: We suggest that the jugular access should be chosen in patients who need long term catheterization because of high 
incidence of mechanical complication, such as pinch-off syndrome.
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Introduction
Central venous catheters (CVCs) are needed for the clinical management of malignant and benign conditions. Indications for 
CVC placement include safe administration of parenteral nutrition, specific drugs (e.g., catecholamines), and hemodynamic 
monitoring.[1] In particular, CVCs have become an important part of managing cancer patients because of the administration 
of supportive blood products, antiemetics, antibiotics, analgesics, and continual chemotherapy or other systemic therapy.[2] 
However, repeated venipuncture may cause physical and psychological trauma to patients.
Broviac et al[3] were the first to describe a long term ve-
nous catheter system, and since then the totally implantable 
access port (TIAP) has been used for cancer patients.[4]
The TIAP provides reliable, long-term vascular access with 
minimal risk of infection while allowing patients to continue 
normal physical activity.[4] However, approximately 15% of 
patients with TIAP experience catheter-related complications.
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[5] Previous research has found that TIAP complication 
rates differed according to central venous access routes.[6-
9] Furthermore, there is no consensus on whether a central 
venous insertion site is less prone to complications. 
Therefore, the purpose of this study was to analyze TIAP-
related complications that were all performed at a single 
institution and to evaluate the outcomes of two different 
percutaneous routes (internal jugular and subclavian) as ac-
cess to superior vena cava.
Materials and Methods
This study included 171 patients who underwent an im-
plantation with a Bard PortTM (Bard Inc., Salt Lake City, UT, 
USA) constructed of titanium and silicon rubber with 6 Fr 
polyurethane catheter tubing attached. The implantations 
were performed by a single surgeon between August 2011 
and May 2013 and the results were retrospectively analyzed. 
All subcutaneous port devices were implanted via percutane-
ous landmark access with fluoroscope guidance to the inter-
nal jugular vein or via infraclavicular access to the subclavian 
vein. All implantations occurred under local anesthesia in an 
operating room, using standard surgical sterile techniques, 
and a chest X-ray was always performed after implantation.
Patients were divided into two Groups; Group 1 (internal 
jugular access) and Group 2 (subclavian access). Patient 
characteristics, including diagnosis, port placement sites, 
Table 1. Baseline characteristics of patients
Group 1 Group 2 Total
Total patients, No. (%) 92 (53.8) 79 (46.2) 171 (100)
Age (year)
Median 62 57 59
Range 1-82 15-77 1-82
Gender, No. (%)
Male 34 (37.0) 24 (30.4)   58 (33.9)
Female 58 (63.0) 55 (69.6) 113 (66.1)
Type of disease, No. (%)
Malignancy 85 (92.4) 77 (97.5) 162 (94.7)
Brain   0 (0)   1 (1.3)     1 (0.6)
Head and neck   1 (1.1)   1 (1.3)     2 (1.2)
Breast 18 (19.6) 22 (27.8)   40 (24.7)
Lung 16 (17.4)   4 (5.0)   20 (12.3)
Thymus   0 (0)   1 (1.3)     1 (0.6)
Esophagus   1 (1.1)   4 (5.0)     5 (3.0)
Stomach 13 (14.1) 17 (21.5)   30 (18.5)
Colon   0 (0)   2 (2.5)     2 (1.2)
Genital   6 (6.5)   5 (6.3)   11 (6.8)
Bone   3 (3.3)   3 (3.8)     6 (3.7)
Leukemia   0 (0)   2 (2.5)     2 (1.2)
Lymphoma 27 (29.3) 15 (19.0)   42 (25.9)
Benign   7 (7.6)   2 (2.5)     9 (5.3)
Side, No. (%)*
Right 81 (88.0) 20 (25.3) 101 (59.1)
Left 11 (12.0) 59 (74.7)   70 (40.9)
Data are shown as number of patients with percentages in parentheses.
*p < 0.05 (statistical comparison by chi square test).
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and port-related complications were collected. Port-related 
complications were documented in accordance with the 
Society of Interventional Radiology reporting standards.
[6] Data were collected until the device was removed or the 
patient passed away. The comprehensive database was ap-
proved by the Institutional Review Board. 
Independent t-tests, Fisher exact and chi square tests were 
used to compare the clinico-pathologic characteristics and 
evaluate the outcomes of two different percutaneous routes 
of access to superior vena cava. Kaplan-Meier and log rank 
tests were used to demonstrate the mechanical complication-
free probability between each intravenous access. All analy-
ses were performed with SPSS version 13.0 for Windows 
(SPSS, Chicago, IL, USA).
Ethics statement
The study protocol was approved by the institutional 
review board by Yonsei University Wonju College of Medi-
cine (approval number YUMC-13-5-073). Informed consent 
was waived by the institutional review board.
Results
Table 1 shows patient characteristics. Of 171 patients, 58 
(33.9%) were male and 113 (35.3%) were female. Median 
follow-up for TIAP was 278 days (range, 1–1,868). Median 
age at time of port placement was 59 years (range, 1-82). 
Indications for TIAP included chemotherapy for solid organ 
malignancy (n = 118, 69.0%), lymphoproliferative disorder 
(n = 44, 25.7%), and a benign condition (n = 9, 5.3%). The 
preferred site of access was the right internal jugular vein (n 
= 81) in group 1. However, left subclavian access was more 
frequent in group 2 (n = 59). There were no statistical dif-
ferences in the baseline characteristics of patients except the 
laterality of percutaneous access route to superior vena cava.
Procedural complications are listed in Table 2. Twenty 
four complications occurred (14.0%), including pneumo-
thorax (n = 1, 0.6%), migration/malposition (n = 4, 2.3%), 
pinch-off syndrome (n = 4, 2.3%), malfunction (n = 3, 1.8%), 
local infection (n = 8, 4.7%), port related bacteremia (n = 3, 
1.8%), and venous thrombosis (n = 5, 2.9%). The overall in-
cidence was 8.7% and 20.3% in each group (p = 0.030). All 
Table 2. Comparison of port related complications
Group 1 Group 2 p-value
Mechanical complications, No. (%) 2 (2.2)   9 (11.4) 0.033
Pneumothorax 0 (0.0) 1 (1.3) 0.462
Hemothorax 0 (0.0) 0 (0.0) -
Migration/malposition 1 (1.1) 3 (3.8) 0.336
Pinch off syndrome 0 (0.0) 4 (5.1) 0.044
Malfunction 1 (1.1) 1 (1.3) 1.000
Infectious complications, No. (%) 4 (4.3) 4 (5.1) 1.000
Thrombotic complications, No. (%) 2 (2.2) 3 (3.8) 0.663
Total, No. (%) 8 (8.7) 16 (20.3) 0.030
Data are shown as number of patients with percentages in parentheses.
Fig. 1. The mechanical complication free probability between 
two groups.
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patients with port related complications underwent TIAP 
removal. Mechanical complications, except infectious and 
thrombotic complications, occurred more often in group 2 (p 
= 0.033), and pinch-off syndrome only occurred in group 2. 
The mechanical complication-free probability was signifi-
cantly different between the 2 groups according to Kaplan-
Meier and log rank tests (p = 0.040, Fig. 1).
Discussion
Over the past 50 years, there have been significant techni-
cal advances in the management of central venous catheters.
[1,2] The TIAP has been extensively used world-wide to 
improve patient convenience and quality of life.[1,2,7] The 
access vein varied according to surgeon’s preference. How-
ever, the choice of access route is critical for predicting port 
implantation complications. Until now, the subclavian and 
internal jugular veins were the most common percutaneous 
routes of access to superior vena cava.[7-11] In the past, the 
subclavian vein has been the most popular route for place-
ment of central venous catheters.[10,12,13] In the present 
study, a chronological change from subclavian to internal 
jugular access was also observed.
Several recent studies reported that the complication rate 
of TIAPs varied between 6-21%.[13] Historically, TIAPs 
have been associated with mechanical, infectious, and 
thrombotic complications.[4-13] Recently, a review of the 
Cochrane Database of Systemic Reviews concluded that 
subclavian and internal jugular central venous access (CVA) 
routes have similar risks for catheter-related complications 
in long-term catheterization in cancer patients.[14] Biffi et 
al. also demonstrated that CVA site had no impact on early 
and late complication rates.[8] However, another review 
found that the subclavian approach had a higher risk of 
malpositions,[1] while other studies recommend the internal 
jugular vein because the subclavian approach has a higher 
incidence of mechanical complications.[8-10] In our study, 
mechanical complications happened significantly more of-
ten with the subclavian approach according to the Kaplan-
Meier and log rank tests. In particular, pinch-off syndrome 
only occurred in subclavian group. Pinch-off syndrome is 
defined as the anatomical compression of a catheter be-
tween the clavicle and first costoclavicular space, leading 
to fracture, transection, or embolization of the catheter.
[15] Aitken et al[16] suggested that prompt removal of the 
catheter was required in patients with pinch-off syndrome. 
Interestingly, immediate catheter malpositioning did not 
occur in our series. Araújo et al[10] reported 15 cases of 
immediate catheter malpositioning. These discrepancies 
regarding the incidence of catheter malpositioning may be 
partly due to the use of image-guided CVA. The present 
study used fluoroscope-guided access in all patients. In re-
cent years, ultrasound, venography, and fluoroscope-guided 
access have become widely used for reducing postoperative 
complications and mal-positioning.[9] The current study 
found that infectious and thrombotic complications did not 
differ significantly between groups, which is consistent with 
previous studies.[1,7-14] 
Many clinicians prefer the superior vena cava route via 
the right-sided approach due to the shorter length of catheter 
required for implantation. Left-sided approaches are used 
in certain clinical situations, such as in patients who had 
been previously implanted with a right-sided intravenous 
port, or underwent a right-modified radical mastectomy.
[6] In our study, the left subclavian approach was com-
monly performed to prevent catheter kinking because the 
left subclavian vein runs to the brachiocephalic vein at an 
obtuse angle.[17] However, 14 of 16 complications (87.5%) 
occurred using the left subclavian catheter compared to the 
right subclavian catheter, although this difference was not 
statistically significant. Thrombosis and pneumothorax were 
only developed in left subclavian TIAP. These data should 
be interpreted with caution because the left subclavian ap-
proach may be more prone to TIAP-related complications. 
In addition, previous studies have demonstrated that TIAP 
complication rates vary among surgeons according to level 
of surgical experience,[4,11] with the highest complication 
rates observed in trainees.[4,11] In the present study, one 
cardiovascular surgeon performed all TIAP implantations.
The present study was limited by its nonrandomized, ret-
rospective design. Subclavian access was preferred in the 
early insertion period, but a shift to internal jugular access 
was noted later. In addition, although there were no signifi-
cant differences in complication rates, the laterality of ac-
cess vein differed between groups. Finally, the study sample 
included two pediatric patients, but pediatric anatomical 
characteristics such as small vessels were not considered 
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when making comparisons in the present study.
As a result, we recommend jugular access in patients who 
require long-term catheterization, because the subclavian 
approach is associated with a high incidence of mechanical 
complications, such as pinch-off syndrome. However, more 
research on this topic is needed in order to better understand 
the association between surgical complications and percuta-
neous routes of access to superior vena cava.
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